WebSep 5, 2013 · Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced the pricing of $700 million aggregate principal amount of convertible senior unsecured notes that will be issued in two series, with one series of $300 million aggregate principal amount maturing on September 1, 2024 (the 2024 notes) and the other series of $400 million aggregate … WebApr 6, 2024 · 14 brokers have issued 1 year price objectives for Apellis Pharmaceuticals' shares. Their APLS share price forecasts range from $40.00 to $139.00. On average, they predict the company's share price to reach $78.40 in the next twelve months. This suggests that the stock has a possible downside of 0.5%.
CUBIST PHARM : Cubist Pharmaceuticals Appoints Charles …
WebCubist Pharmaceuticals Price History Delisted . USA . . Cubist Pharmaceuticals Summary Forecast As of today, the current price of Cubist Pharmaceuticals is 0.00 , as … WebDec 8, 2014 · NEW YORK ( TheStreet) -- Shares of Cubist Pharmaceuticals ( CBST) are up 36.01% to $101.14 in pre-market trade after it was reported that Merck & Co. ( MRK) - … the munster cast
Cubist Pharmaceuticals, Inc. (CBST) to Ring The NASDAQ Stock …
WebApr 11, 2024 · 12 analysts have issued 1 year price objectives for Xenon Pharmaceuticals' stock. Their XENE share price forecasts range from $45.00 to $60.00. On average, they anticipate the company's share price to reach $50.70 in the next year. This suggests a possible upside of 50.2% from the stock's current price. View analysts price targets for … WebCubist Pharmaceuticals's latest funding round was a Acquired for on December 8, 2014. Cubist Pharmaceuticals's latest post-money valuation is from December 2014. Sign up for a free trial to see Cubist Pharmaceuticals's valuations in December 2014 and more. WebApr 11, 2024 · In other Enanta Pharmaceuticals news, CEO Jay R. Luly sold 27,912 shares of the firm’s stock in a transaction on Monday, March 13th. The stock was sold at an average price of $45.16, for a total ... how to disable dashlane on my computer